Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

From Facebook Ok. I’ve spent 22 years in big

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 153864
(Total Views: 702)
Posted On: 02/01/2021 5:00:56 PM
Posted By: reallypeople?
From Facebook

Ok. I’ve spent 22 years in big pharma. Unblinding can only happen AFTER a few key steps. To-date, only the unblinded statistician has access to the blinding codes. Nobody else and cannot release them until there is a massive sign off of documents to allow for unblinding.

1.) Obviously all patients need to be finished with the study. Either had their last study visit (last study visit or died) or confirmed to be lost to follow-up.

2.) all patient data must be entered into the study database.

3.) all vendor data must be cleaned, validated by QC, and transferred into the study database.

4.) all patient data thats been entered must be ‘cleaned’ which means all discrepancies in the data must be corrected or explained.

5.) all SAEs must be reconciled against the clinical database.

6.) the database must be ‘frozen’ so no changes can be made. This is then reviewed by QC.

7.) draft tables, listings, and figures (TLFs) must be printed (PDF) for top line review. This will most likely be literally 10’s of thousands of pages of data that needs to be reviewed by the signatories to confirm accuracy of the clinical data. This could require several rounds of database corrections if errors are found.

8.) the statistical analysis plan (SAP) must be finalized and approved.

8.) once the draft TLFs are signed, only then can the signatures be made to certify that the database can be unblinded.

9.) the unblinded statistician is only then allowed to ‘flip the switch’ and unblind the study.

There are lots of details that would make this list way too long and cumbersome to type on my phone. This is not a quick process. I believe CYDY and the CRO are working at ‘warp speed’ - pardon the pun - to get this finished as soon as humanly possible. I’ve been hearing the switch will be flipped this week.


(8)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us